329 Superkine IL-2 and IL-33 armored CAR T cells reshape the tumor microenvironment to universally reduce solid tumors

Abstract

BackgroundCAR T cell efficacy against solid tumors is challenged by key obstacles present within the tumor microenvironment (TME). These include tumor-intrinsic expression of inhibitory ligands that induce T cell exhaustion,...